3004.90.92.12 - Other 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS subheading, 3004.90.92.12, covers antiprotozoal medicaments that do not fall under the specific exclusions outlined in Chapter 30, Note 2. These are medicinal preparations containing mixed or unmixed products specifically for treating or preventing protozoal infections. They must be presented in measured doses, such as tablets, capsules, or injectables, or in forms suitable for retail sale, including transdermal systems.
This category is distinguished from its sibling, 3004.90.92.08, by its exclusion of medicaments containing metronidazole or its salts. Therefore, if a medicament has antiprotozoal therapeutic use and is not an antiprotozoal containing metronidazole, it would likely be classified here. The "Other" descriptors at this granular level indicate that after broader antiprotozoal classifications have been made, this subheading captures remaining antiprotozoal medicaments that don't fit more specific sub-classifications within the antiprotozoal group.
As this is a leaf node, there are no further subcategories to introduce. Classification under 3004.90.92.12 hinges on the absence of metronidazole or its salts within the antiprotozoal formulation, while still meeting the general requirements for medicaments in measured doses or for retail sale. Examples might include specific antimalarial or amoebicide preparations not containing metronidazole.